InvestorsHub Logo
Followers 38
Posts 2382
Boards Moderated 0
Alias Born 05/13/2007

Re: None

Friday, 12/09/2022 10:38:59 AM

Friday, December 09, 2022 10:38:59 AM

Post# of 232585
While the previous CEO, Nader, had a great drug but moved forward like a professional scammer and burned down our great chances for HIV and COVID, the new future CEO is of a different calibre. He keeps quiet most of the time- good, but not good enough! A few days ago, the last information was excellent and confirmed with possible certainty by top external doctors that the drug has a great future for many, if not countless, diseases. All the available results are great - of course, from a formal view, not good enough for approval any time soon, in fact, years away.

Unfortunately, at the end of the call, unnecessary info about the "FDA- hold" and partnerships was released, which gives shorters a clear timeline about their timeframe for continuous shorting. I thought Cyrus would have learned his lessons in the past- obviously not. Shorters and MMs are starting to love him. This was unnecessary favour for them.

We don't need info about the following:
* Amarex: we know they will pay when the time comes. The announcement will come as a surprise.
* FDA- Hold: time will come, maybe in 4 weeks, maybe in 2 months. No need to talk about it. The "hold" will be released. keep quiet.
* Partnership: will come for Oncology, the last info gives me a 100% certainty. We know it will not happen before lifting the "Hold"

I believe it will take us to mid of February before we will see sp moving up again - in the meantime shorters will play us with pleasure as president is talking too much about timelines.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News